Abstract:Membrane integrity is essential for cellular survival and function. The spectrum of mechanisms protecting cellular and intracellular membranes is not fully known. Our recent work has uncovered a cellular system termed MERIT for lysosomal membrane repair, removal and replacement. Specifically, lysosomal membrane damage induces, in succession, ESCRT-dependent membrane repair, macroautophagy/autophagy-dominant removal of damaged lysosomes, and initiation of lysosomal biogenesis via transcriptional programs. The MERIT system is governed by galectins, a family of cytosolically synthesized lectins recognizing β-galactoside glycans. We found in this study that LGALS3 (galectin 3) detects membrane damage by detecting exposed lumenal glycosyl groups, recruits and organizes ESCRT components PDCD6IP/ALIX, CHMP4A, and CHMPB at damaged sites on the lysosomes, and facilitates ESCRT-driven repair of lysosomal membrane. At later stages, LGALS3 cooperates with TRIM16, an autophagy receptor-regulator, to engage autophagy machinery in removal of excessively damaged lysosomes. In the absence of LGALS3, repair and autophagy are less efficient, whereas TFEB nuclear translocation increases to compensate lysosomal deficiency via de novo lysosomal biogenesis. The MERIT system protects endomembrane integrity against a broad spectrum of agents damaging the endolysosomal network including lysosomotropic drugs, Mycobacterium tuberculosis, or neurotoxic MAPT/tau. Abbreviations: AMPK: AMP-activated protein kinase; APEX2: engineered ascorbate peroxidase 2; ATG13: autophagy related 13; ATG16L1: autophagy related 16 like 1; BMMs: bone marrow-derived macrophages; ESCRT: endosomal sorting complexes required for transport; GPN: glycyl-L-phenylalanine 2-naphthylamide; LLOMe: L-leucyl-L-leucine methyl ester; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MERIT: membrane repair, removal and replacement; MTOR: mechanistic target of rapamycin kinase; TFEB: transcription factor EB; TFRC: transferrin receptor; TRIM16: tripartite motif-containing 16.

LYSET/TMEM251- a novel key component of the mannose 6-phosphate pathway

LYSET/TMEM251/GCAF is critical for autophagy and lysosomal function by regulating the mannose-6-phosphate (M6P) pathway

Lysosomal enzyme trafficking factor LYSET enables nutritional usage of extracellular proteins

GCAF(TMEM251) regulates lysosome biogenesis by activating the mannose-6-phosphate pathway

The human disease gene LYSET is essential for lysosomal enzyme transport and viral infection

Molecular Insights into the Regulation of GNPTAB by TMEM251

TMEM175: A Lysosomal Ion Channel Associated with Neurological Diseases

Structure of a truncated human GlcNAc-1-phosphotransferase variant reveals the basis for its hyperactivity

Site-1 Protease Deficiency Causes Human Skeletal Dysplasia

Mannose-6-phosphate glycan for lysosomal targeting: various applications from enzyme replacement therapy to lysosome-targeting chimeras

Structure of the human GlcNAc-1-phosphotransferase αβ subunits reveals regulatory mechanism for lysosomal enzyme glycan phosphorylation.

TMEM241 is a UDP-N-acetylglucosamine transporter required for M6P modification of NPC2 and cholesterol transport

Structural insights into how GlcNAc-1-phosphotransferase directs lysosomal protein transport

Lysosomal enzyme trafficking: from molecular mechanisms to human diseases

MERIT, a cellular system coordinating lysosomal repair, removal and replacement

GRASP55 Safeguards Proper Lysosome Function by Controlling Sorting of Lysosomal Enzymes at the Golgi

Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras

A bacterial glycosidase enables mannose-6-phosphate modification and improved cellular uptake of yeast-produced recombinant human lysosomal enzymes

The lysosomal trafficking regulator "LYST": an 80-year traffic jam

A key enzyme in the biogenesis of lysosomes is a protease that regulates cholesterol metabolism

Characterization of the Role of TMEM175 in an in Vitro Lysosomal H+ Fluxes Model.